Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Retraction Note: mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia.
Journal: Molecular psychiatry
Published: April 17, 2025
mGluR5 hypofunction is integral to glutamatergic dysregulation in schizophrenia.
Journal: Molecular psychiatry
Published: April 25, 2018
Taurine Targets the GluN2b-Containing NMDA Receptor Subtype.
Journal: Advances in experimental medicine and biology
Published: April 03, 2015
Showing 1-4 of 4
Last Updated: 09/26/2026